Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Charles River Laboratorie...

    NYSE: CRL · Real-Time Price · USD
    144.66
    3.46 (2.45%)
    At close: Jun 06, 2025, 3:59 PM
    144.70
    0.03%
    After-hours: Jun 06, 2025, 05:59 PM EDT

    Charles River Laboratories International Statistics

    Share Statistics

    Charles River Laboratories International has 49.12M shares outstanding. The number of shares has increased by -0.72% in one year.

    Shares Outstanding

    n/a
    		 49.12M

    Shares Change (YoY)

    n/a
    		 -0.72%

    Shares Change (QoQ)

    n/a
    		 0.01%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 23

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 2.76M, so 5.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.76M

    Short % of Shares Out

    n/a
    		 5.4%

    Short % of Float

    n/a
    		 7.01%

    Short Ratio (days to cover)

    n/a
    		 1.63

    Valuation Ratios

    The PE ratio is 926.84 and the forward PE ratio is 13.86. Charles River Laboratories International's PEG ratio is -9.99.

    PE Ratio

    n/a
    		 926.84

    Forward PE

    n/a
    		 13.86

    PS Ratio

    n/a
    		 2.36

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 2.76

    P/FCF Ratio

    n/a
    		 19.03

    PEG Ratio

    n/a
    		 -9.99
    Financial Ratio History

    Enterprise Valuation

    Charles River Laboratories International has an Enterprise Value (EV) of 12.07B.

    EV / Sales

    n/a
    		 2.98

    EV / EBITDA

    n/a
    		 20.77

    EV / EBIT

    n/a
    		 16.44

    EV / FCF

    n/a
    		 24.07

    Financial Position

    The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.79.

    Current Ratio

    n/a
    		 1.41

    Quick Ratio

    n/a
    		 1.13

    Debt / Equity

    n/a
    		 0.79

    Debt / EBITDA

    n/a
    		 4.69

    Debt / FCF

    n/a
    		 5.43

    Interest Coverage

    n/a
    		 1.8

    Financial Efficiency

    Return on Equity is 0.3% and Return on Invested Capital is 0.95%.

    Return on Equity

    n/a
    		 0.3%

    Return on Assets

    n/a
    		 0.14%

    Return on Invested Capital

    n/a
    		 0.95%

    Revenue Per Employee

    n/a
    		 $216,576.95

    Profits Per Employee

    n/a
    		 $550.64

    Employee Count

    n/a
    		 18,700

    Asset Turnover

    n/a
    		 0.54

    Inventory Turnover

    n/a
    		 9.76

    Taxes

    Income Tax

    n/a
    		 67.82M

    Effective Tax Rate

    n/a
    		 72.84%

    Stock Price Statistics

    The stock price has increased by -36.14% in the last 52 weeks. The beta is 1.48, so Charles River Laboratories International's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.48

    52-Week Price Change

    n/a
    		 -36.14%

    50-Day Moving Average

    n/a
    		 130.13

    200-Day Moving Average

    n/a
    		 171.21

    Relative Strength Index (RSI)

    n/a
    		 56.92

    Average Volume (20 Days)

    n/a
    		 1,629,611

    Income Statement

    In the last 12 months, Charles River Laboratories International had revenue of 4.05B and earned 10.3M in profits. Earnings per share was 0.67.

    Revenue

    n/a
    		 4.05B

    Gross Profit

    n/a
    		 1.33B

    Operating Income

    n/a
    		 227.35M

    Net Income

    n/a
    		 10.3M

    EBITDA

    n/a
    		 581.14M

    EBIT

    n/a
    		 219.4M

    Earnings Per Share (EPS)

    n/a
    		 0.67
    Full Income Statement

    Balance Sheet

    The company has 194.61M in cash and 2.72B in debt, giving a net cash position of -2.53B.

    Cash & Cash Equivalents

    n/a
    		 194.61M

    Total Debt

    n/a
    		 2.72B

    Net Cash

    n/a
    		 -2.53B

    Retained Earnings

    n/a
    		 1.81B

    Total Assets

    n/a
    		 7.58B

    Working Capital

    n/a
    		 455.3M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 734.58M and capital expenditures -232.97M, giving a free cash flow of 501.61M.

    Operating Cash Flow

    n/a
    		 734.58M

    Capital Expenditures

    n/a
    		 -232.97M

    Free Cash Flow

    n/a
    		 501.61M

    FCF Per Share

    n/a
    		 9.78
    Full Cash Flow Statement

    Margins

    Gross margin is 32.88%, with operating and profit margins of 5.61% and 0.25%.

    Gross Margin

    n/a
    		 32.88%

    Operating Margin

    n/a
    		 5.61%

    Pretax Margin

    n/a
    		 2.3%

    Profit Margin

    n/a
    		 0.25%

    EBITDA Margin

    n/a
    		 14.35%

    EBIT Margin

    n/a
    		 5.61%

    FCF Margin

    n/a
    		 12.39%

    Dividends & Yields

    CRL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.11%

    FCF Yield

    n/a
    		 5.26%
    Dividend Details

    Analyst Forecast

    The average price target for CRL is $178.5, which is 26.1% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $178.5

    Price Target Difference

    n/a
    		 26.1%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 14
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $3.35

    Lynch Upside

    n/a
    		 -97.63%

    Graham Number

    n/a
    		 17.47

    Graham Upside

    n/a
    		 -87.66%

    Scores

    Altman Z-Score

    n/a
    		 1.93

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist